-
Loading metrics
Remdesivir-bisPropionate, a better derivative of remdesivir against SARS-CoV-2: Comparison of in vitro and in vivo PK/PD Study as well as its therapeutic potential
- Ashok Chakraborty,
- Anil Diwan,
- Vijetha Chiniga,
- Vinod Arora,
- Yogesh Thakur,
- Jayant Tatake,
- Rajesh Pandey,
- Preetam Holkar,
- Neelam Holkar
x
- Published: February 20, 2026
- https://doi.org/10.1371/journal.pone.0324811